ArticleJournal of experimental & clinical cancer research : CR2024

SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4.

Jizhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.